FV
Farhan Vali Mohammed Shekhani
About Farhan Vali Mohammed Shekhani
Data last updated:
Farhan Vali Mohammed Shekhani is a Designated Partner at Icon Pharmaceuticals Llp (since 2021). The company operates in Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Icon Pharmaceuticals Llp AAX-4531 | Designated Partner | 04 Dec 2021 | 2021 | Under Process Of Striking Off |
Board colleagues of Farhan Vali Mohammed Shekhani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Tiwari | 09185182 | Icon Pharmaceuticals Llp | Designated Partner |
| Arvindkumar Surendra Singh | 09185145 | Icon Pharmaceuticals Llp | Designated Partner |
| Gyanendra Sakalnarayan Singh | 09186617 | Icon Pharmaceuticals Llp | Designated Partner |
| Mohd Rizwan Muriajaali Pathan | 09185367 | Icon Pharmaceuticals Llp | Designated Partner |
| Vinaykumar Sheshdhar Pandey | 09185146 | Icon Pharmaceuticals Llp | Designated Partner |
| Wajid Ismail Memon | 09400179 | Icon Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Farhan Vali Mohammed Shekhani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Farhan Vali Mohammed Shekhani
Farhan Vali Mohammed Shekhani currently holds 1 directorship: Icon Pharmaceuticals Llp (Designated Partner, since 04 Dec 2021).
Farhan Vali Mohammed Shekhani was first appointed on 04 Dec 2021 as Designated Partner at Icon Pharmaceuticals Llp.
The current boards of Farhan Vali Mohammed Shekhani's companies include Amit Tiwari (Icon Pharmaceuticals Llp), Arvindkumar Surendra Singh (Icon Pharmaceuticals Llp), Gyanendra Sakalnarayan Singh (Icon Pharmaceuticals Llp), Mohd Rizwan Muriajaali Pathan (Icon Pharmaceuticals Llp), Vinaykumar Sheshdhar Pandey (Icon Pharmaceuticals Llp), Wajid Ismail Memon (Icon Pharmaceuticals Llp).